Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective
Angulo, J.C., Sánchez-Ballester, F., Peral, C., Rejas, J., Ramos, J., Snedecor, S.J., Sudharshan, L., Liu, S., Luo, X.Language:
english
Journal:
Actas Urológicas Españolas (English Edition)
DOI:
10.1016/j.acuroe.2016.07.006
Date:
August, 2016
File:
PDF, 810 KB
english, 2016